353-09-3
353-09-3
Chemical Structure
Ompenaclid
Synonym(s): RGX-202; 3-Guanidinopropionic acid
- CAS No.: 353-09-3
- Formula:C4H9N3O2
- Molecular Weight:131.14
IUPAC Name: 3-guanidinopropanoic acid
InChIKey: KMXXSJLYVJEBHI-UHFFFAOYSA-N
SMILES: O=C(O)CCNC(N)=N
Biological Activity: Ompenaclid (RGX-202) is an oral small-molecule SLC6A8 transporter inhibitor. Ompenaclid robustly inhibits creatine import in vitro and in vivo, reduces intracellular phosphocreatine and ATP levels, and induces tumor apoptosis. Ompenaclid can be used for the research of cancer and duchenne muscular dystrophy[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ompenaclid | 99.94% | Ompenaclid (RGX-202) is an oral small-molecule SLC6A8 transporter inhibitor. Ompenaclid robustly inhibits creatine import in vitro and in vivo, reduces intracellular phosphocreatine and ATP levels, and induces tumor apoptosis. Ompenaclid can be used for the research of cancer and duchenne muscular dystrophy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ompenaclid (Standard) | ≥98% | Ompenaclid (RGX-202) is an oral small-molecule SLC6A8 transporter inhibitor. Ompenaclid robustly inhibits creatine import in vitro and in vivo, reduces intracellular phosphocreatine and ATP levels, and induces tumor apoptosis. Ompenaclid can be used for the research of cancer and duchenne muscular dystrophy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Argininic acid | 99.91% | Argininic acid is an α-amino acid that is used in the biosynthesis of proteins. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ureidopropionic acid (Standard) | 99.96% | Ureidopropionic acid (Standard) is the analytical standard of Ureidopropionic acid. This product is intended for research and analytical applications. Ureidopropionic acid (3-Ureidopropionic acid) is a selective mitochondrial respiratory chain complex V inhibitor. Ureidopropionic acid induces the production of reactive oxygen species, delayed elevation of intracellular calcium concentration, secondary energy-dependent excitotoxicity and neurodegeneration in neurons. Ureidopropionic acid promotes neuropathological changes by impairing mitochondrial energy metabolism, oxidative stress and excitotoxicity pathways. Ureidopropionic acid can be used in studies related to 3-ureidopropionase deficiency and severe propionic aciduria. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Guanidinobutanoic acid (Standard) | ≥98% | 4-Guanidinobutanoic acid (Standard) is the analytical standard of 4-Guanidinobutanoic acid (HY-113286). This product is intended for research and analytical applications. 4-Guanidinobutanoic acid is a metabolite of arginine and an orally active SLC36A1/Hedgehog signaling pathway activator. 4-Guanidinobutanoic acid drives epithelial reprogramming, enhances intestinal stem cell function and goblet cell differentiation. 4-Guanidinobutanoic acid promotes the enrichment of Akkermansia muciniphila via mucus-dependent niche expansion, regulates intestinal homeostasis, and establishes a microbiota-host feedback loop. 4-Guanidinobutanoic acid exhibits anti-aging and healthspan-regulating properties. 4-Guanidinobutanoic acid can be used in research related to ulcerative colitis, amyotrophic lateral sclerosis, and Duchenne muscular dystrophy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-Oxoarginine | 99.15% | 2-Oxoarginine (α-keto-δ-Guanidinovaleric acid) is an Arginine impurity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Guanidinobutanamide | 4-Guanidinobutanamide is a nucleoside metabolite. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Arginine | 98.0% | DL-Arginine is the racemic compound of L-Arginine (HY-N0455) and D-Arginine (HY-W016781). Arginine is an essential amino acid that requires additional supplementation in traumatic or diseased conditions. Arginine is involved in T cell activation, proliferation, and differentiation, and affects the function of immune cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Arginine | 99.89% | L-Arginine ((S)-(+)-Arginine) is the substrate for the endothelial nitric oxide synthase (eNOS) to generate NO. L-Arginine is transported into vascular smooth muscle cells by the cationic amino acid transporter family of proteins where it is metabolized to nitric oxide (NO), polyamines, or L-proline. L-Arginine is a potent vasodilator, and can be used to induce experimental acute pancreatitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Arginine (Standard) | ≥98% | D-arginine (H-D-Arg-OH) is the D-isomer of arginine. Arginine is an α-amino acid that is used in the biosynthesis of proteins. D-Arginine is an inactive form of L-arginine. D-arginine can be used in myeloma and neurological disease research.. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycocyamine | 99.96% | Glycocyamine (Guanidinoacetic acid) is a direct precursor of creatine and an orally active energy metabolism regulator and myogenic differentiation inducer. Glycocyamine can activate the Akt/mTOR/S6K signaling pathway via miR-133a-3p and miR-1a-3p, and stimulate the mRNA expression of myogenic differentiation factor 1 (MyoD) and myopoietin (MyoG). Glycocyamine can increase muscle creatine concentration and maintain ATP homeostasis through the creatine phosphate/creatine kinase system. Glycocyamine can be used in research on feed additives for poultry farming. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycocyamine-15N,13C2 | 97.40% | Glycocyamine-15N,13C2 (Guanidinoacetic acid-15N,13C2) is the 13C and 15N labeled Glycocyamine (HY-W021448). Clycocyamine is a direct precursor of creatine and an orally active energy metabolism regulator and myogenic differentiation inducer. Glycocyamine can activate the Akt/mTOR/S6K signaling pathway via miR-133a-3p and miR-1a-3p, and stimulate the mRNA expression of myogenic differentiation factor 1 (MyoD) and myopoietin (MyoG). Glycocyamine can increase muscle creatine concentration and maintain ATP homeostasis through the creatine phosphate/creatine kinase system. Glycocyamine can be used in research on feed additives for poultry farming. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Kurth I, et al. Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels. Sci Adv. 2021 Oct 8;7(41):eabi7511. [Content Brief]
- [2]. Creisméas A, et, al. TRPC1 and TRPC3 involvement in DMD physiopathology and as potential targets for treatment in complement to rAAV-microdystrophin. 2021 Oct 1;13.
